| CAS | Product Name | MF |
|
2565657-65-8
|
3-Pyrrolidineacetic acid, α-[(3-bromophenyl)methyl]-1-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester, (αS,3R)-
|
C22H32BrNO4
|
|
27252-80-8
|
Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-(2-propenyloxy)-
|
(C2H4O)nC4H8O
|
|
99126-64-4
|
MONO-METHYL POLYETHYLENE GLYCOL 5'000 2-MALEIMIDOETHYL ETHER
|
(C2H4O)nC7H9NO3
|
|
1818294-45-9
|
Azido-PEG12-t-butyl ester
|
(C2H4O)nC9H17N3O3
|
|
1257517-66-0
|
4-Bromo-2,3-dichlorobenzoic acid
|
C7H3BrCl2O2
|
|
2074615-22-6
|
Cinacalcet Impurity 13
|
C22H22F3N
|
|
57171-18-3
|
KEMXOZSBCMOIEF-LECWWXJVSA-N
|
C24H30O6
|
|
37625-56-2
|
POLYCAPROLACTONE TRIOL AVERAGE MN CA.
|
(C6H14O3.C6H10O2)x
|
|
560069-78-5
|
EUROPIUM(III) BROMIDE HYDRATE 99.99+ %
|
Br3EuH2O
|
|
1638785-19-9
|
methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate
|
C13H15ClO3
|
|
2189684-44-2
|
Lenacapavir
|
C39H32ClF10N7O5S2
|
|
2222981-71-5
|
MAC glucuronide linker-1
|
C42H47N3O17S
|
|
12111-21-6
|
Phosphate Buffer solution
|
C14H13MnO4
|
|
11032-98-7
|
tylosin B
|
C39H65NO14
|
|
817562-90-6
|
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester, (αR)-
|
C35H64N4O10
|
|
239807-03-5
|
Voriconazole Impurity 8
|
C16H14F3N5O
|
|
2346581-96-0
|
m-PEG17-acid
|
C36H72O19
|
|
2457232-14-1
|
4-((5-Oxo-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidin-2-yl)amino)thiophene-2-carbonitrile
|
C14H12N4OS
|
|
1321816-57-2
|
Linzagolix choline
|
C27H28F3N3O8S
|
|
2641451-75-2
|
3-Pyridazinecarboxylic acid, 1-[(2S)-3-(4-bromo-2-thiazolyl)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxopropyl]hexahydro-, methyl ester, (3S)-
|
C17H25BrN4O5S
|
|
889672-99-5
|
PFN‐Br
|
(C56H80N2)n.2Br
|
|
1238189-11-1
|
mPEG16-Br
|
C33H67BrO16
|
|
1809224-82-5
|
Dexamethasone EP Impurity K
|
C22H26O4
|
|
910823-84-6
|
(T-4)-[3-Bromo-5-[(4-bromo-3,5-dimethyl-2H-pyrrol-2-ylidene-κN)phenylmethyl]-2,4-dimethyl-1H-pyrrolato-κN]difluoroboron
|
C19H17BBr2F2N2
|
|
117047-08-2
|
Puerarin-4'-O-β-D-glucopyranoside
|
C27H30O14
|
|
104389-32-4
|
POLYISOPRENE TRANS
|
(C5H8)n
|
|
28212-48-8
|
POLY(BIS(PHENOXY)PHOSPHAZENE)
|
(C12H10NO2P)n
|
|
1617-84-1
|
6-O-methylcatalpol
|
C16H24O10
|
|
66514-85-0
|
(R)-ethyl N-formyl-N-(1-phenylethyl)glycine
|
C13H17NO3
|
|
2271036-45-2
|
4-((2-(2-(2-azidoethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
C19H22N6O6
|
|
39464-66-9
|
LAURETH-4 PHOSPHATE
|
(C2H4O)nC12H26O.xH3O4P
|
|
70767-37-2
|
Isooctanoyl chloride
|
C8H15ClO
|
|
84170-27-4
|
Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.-1,6-hexanediylbis.omega.-(1-oxo-2-propenyl)oxy-
|
(C2H4O)n(C2H4O)nC12H18O4
|
|
53067-82-6
|
11A-HYDROXY-18-METHYL-ESTR-4-ENE-3,17-DIONE
|
C19H26O3
|
|
888491-19-8
|
Poly[thieno[3,2-b]thiophene-2,5-diyl(4,4'-ditetradecyl[2,2'-bithiophene]-5,5'-diyl)]
|
(C42H62S4)n
|
|
1509941-93-8
|
Cetirizine Polyethylene Glycol (PEG) Ester
|
(C2H4O)nC21H25ClN2O3
|
|
1207751-12-9
|
Mal-PEG-NH2
|
(C2H4O)nC11H17N3O4
|
|
24393-59-7
|
(E)-Ethyl 3-(2-nitrophenyl)acrylate
|
C11H11NO4
|
|
148579-94-6
|
(25,3R,45,55,65)-2-(4-(hydroxymethyl)-2-nitrophenoxy)-6-(methoxycarbonyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
|
C20H23NO13
|
|
2093197-94-3
|
BDP FL DBCO
|
C32H29BF2N4O2
|
|
1622872-91-6
|
Baceridin
|
C37H57N7O6
|
|
421581-52-4
|
G6PD activator AG1
|
C24H30N4S2
|
|
1951424-92-2
|
Fmoc-Ala-Ala-Asn(Trt)-OH
|
C44H42N4O7
|
|
2446474-09-3
|
Pomalidomide-PEG3-Amine HCl salt
|
|
|
215324-12-2
|
2,5-dioctyloxyterephthalic dihydrazide
|
C24H42N4O4
|
|
2369583-33-3
|
HRX-0215
|
C21H17F2N5O3S
|
|
21291-40-7
|
fructosyl-lysine
|
C12H24N2O7
|
|
52134-62-0
|
8-hydroxymethylriboflavin
|
C17H20N4O7
|
|
864082-49-5
|
5-AMINO-7-CHLORO-1H-INDAZOLE
|
C7H6ClN3
|
|
1394842-91-1
|
Defluoro Paroxetine Hydrochloride
|
|
|
32492-61-8
|
Ethoxylated Bisphenol A
|
(C2H4O)n(C2H4O)nC15H16O2
|
|
28883-63-8
|
Dimethylpolysilane
|
(C2H6Si)n
|
|
2411591-25-6
|
Fmoc-β-Ala-Gln(Trt)-OH
|
C42H39N3O6
|
|
36691-02-8
|
Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-α-ethyl-, ethyl ester
|
C20H21NO3
|
|
1189166-58-2
|
Boron, [5-[(3,5-dimethyl-2H-pyrrol-2-ylidene-κN)phenylmethyl]-2,4-dimethyl-1H-pyrrole-3-carboxaldehydato-κN1]difluoro-, (T-4)-
|
C20H19BF2N2O
|
|
1835667-63-4
|
Befotertinib
|
C29H32F3N7O2
|
|
205494-72-0
|
DPPE-MPEG 5000
|
(C2H4O)nC39H76NO10P
|
|
117230-34-9
|
Soyasaponin Ae
|
C58H90O26
|
|
1413431-46-5
|
Morinidazole Impurity 8
|
C11H18N4O5
|
|
2647442-33-7
|
VV116
|
C24H30DN5O7
|
|
2407854-18-4
|
BMS-502
|
|
|
122375-06-8
|
NHS-PEG-NHS
|
(C2H4O)nC10H8N2O9
|
|
871700-30-0
|
MethaniMidaMide, N'-[1-cyclopropyl-3-(2-fluoro-4-iodophenyl)-1,2,3,6-tetrahydro-2,6-dioxo-4-pyriMidinyl]-N,N-diMethyl-
|
C16H16FIN4O2
|
|
854646-92-7
|
4-tert-Butyl-2,6-dimethyl-alpha-toluic acid
|
C14H20O2
|
|
835595-11-4
|
3,4-dichloro-2-iodobenzenamine
|
C6H4Cl2IN
|
|
105314-53-2
|
(S)-Tomoxetine
|
C17H21NO
|
|
1352085-46-1
|
IDDUCSVQXOGMNE-GVVUEQADSA-N
|
C22H25NO4
|
|
27306-90-7
|
GLYCOLIC ACID ETHOXYLATE LAURYL ETHER
|
(C2H4O)nC14H28O3
|
|
2411592-43-1
|
Fmoc-β-Ala-Glu(OtBu)-OH
|
C27H32N2O7
|
|
870703-61-0
|
6-(DI-BOC-AMINO)-2-BROMOPYRIDINE
|
C15H21BrN2O4
|
|
141283-87-6
|
IS 741
|
C15H20F3N3O3S
|
|
497223-28-6
|
Cenicriviroc
|
C41H52N4O4S.CH4O3S
|
|
773859-49-7
|
BDP FL maleimide
|
C20H21BF2N4O3
|
|
14600-41-0
|
Lincomycin EP Impurity C
|
C17H32N2O6S.ClH
|
|
1019000-64-6
|
PEG2000-C-DMG
|
(C2H4O)nC36H73NO5
|
|
2409130-70-5
|
4,4''-diformyl-[1,1':4',1''-terphenyl]-2',5'-dicarboxylic acid
|
C22H14O6
|
|
2565656-70-2
|
3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (αS,α′S,α′′S,3R,3′R,3′′R)-
|
C42H54N4O6
|
|
1632354-04-1
|
TETRAPEPTIDE-1
|
C20H36N4O6
|
|
41637-38-1
|
BISPHENOL A ETHOXYLATE DIMETHACRYLATE
|
(C2H4O)n(C2H4O)nC23H24O4
|
|
7429-70-1
|
S Tag Peptide
|
C73H117N23O25S
|
|
1100243-40-0
|
Poly[[1,2,3,6,7,8-hexahydro-2,7-bis(2-octyldodecyl)-1,3,6,8-dioxobenzo[lMn][3,8]phenanthroline-4,9-diyl][2,2'-bithiophene]-5,5'-diyl]
|
(C62H88N2O4S2)n
|
|
1421676-62-1
|
Propargyl-PEG13-acid
|
(C2H4O)nC6H8O3
|
|
1573000-28-8
|
[1,1'-Biphenyl]-4-ethanol, α-(chloromethyl)-, (αS)-
|
C15H15ClO
|
|
1415929-80-4
|
poly[(2,6-(4,8-bis(5-(2-ethylhexyl)thiophen-2-yl)-benzo[1,2-b:4,5-b']dithiophene))-alt-(5,5- (1',3'-di-2-thienyl-5',7'-bis(2-ethylhexyl)benzo[1',2'-c:4',5'-c']dithiophene-4,8-dione))]
|
(C68H78O2S8)n
|
|
64844-70-8
|
Piperacillin Impurity 12 Disodium Salt
|
C23H29N5O8S
|
|
79640-70-3
|
Methotrexate α-tert-Butyl Ester
|
C24H30N8O5
|
|
1883528-69-5
|
Ly93
|
C21H20N2O2
|
|
195456-48-5
|
Poly(9,9-dioctyl-9H-fluorene-2,7-diyl)
|
(C29H40)n
|
|
581083-30-9
|
1H-Indazole-3-carboxylic acid, 4,5,6,7-tetrahydro-6,6-diMethyl-
|
C10H14N2O2
|
|
1334850-99-5
|
Mito-TEMPO
|
C29H35N2O2P
|
|
1333317-99-9
|
Poly[bis(4-phenyl)(2,4,6-triMethylphenyl)aMine]
|
(C21H19N)n
|
|
1612756-29-2
|
NAI-N3
|
C10H8N6O
|
|
137405-40-4
|
Fructo-oligosaccharide DP12/GF11
|
C72H122O61
|
|
2022166-57-8
|
5,5-difluoro-2,8-diformyl-1,3,7,9-tetramethyl-10-phenyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide
|
C21H19BF2N2O2
|
|
2089315-59-1
|
3,6-Dichloro-1H-pyrazolo[3,4-d]pyrimidine
|
C5H2Cl2N4
|
|
68647-16-5
|
POLY(ETHYLENE GLYCOL) (200) ADIPATE
|
C6H10O4.x(C2H4O)nH2O
|
|
1265822-30-7
|
CTA056
|
C35H34N6O
|
|
28377-97-1
|
Dodecahydro-arachno-bis(acatonitrile)decaborane
|
C4H18B10N2
|
|
161730-11-6
|
GM-CSF (96-112)
|
C88H139N21O29S
|
|
7559-81-1
|
(2-CHLOROMETHYL)-5-HYDROXY-4H-PYRAN-4-ONE
|
C6H5ClO3
|